OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP April 26, 2014.

Slides:

Advertisements

Similar presentations

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.

Advertisements

TISSUE BANKING Challenging to Say the Least

Office for Human Research Protections 1 Updating the Common Rule Governing Human Subjects Research Protections Jerry Menikoff.

Identifiability: A Useful or Decrepit Concept in Research Ethics? Sara C. Hull, PhD Faculty, Clinical Center Department of Bioethics Director, NHGRI Bioethics.

1  July 26, 2011  60 day public comment period ends: Monday, October 26, 2011 !! Paul J. Reitemeier, Ph.D., Chair Human Research Review Committee Note:

CTSA Implementation at the University of Pennsylvania Carl June, M.D. Professor of Pathology and Lab Medicine Director of Translational Research Institute.

1 OHRP: Activities, Staffing, and Budget Ivor Pritchard, Ph.D. Senior Advisor to the Director Office for Human Research Protections (OHRP)

Proposed Changes to Common Rule Karen Allen Director, Research Protections Office of Research Administration August

Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.

Research, Program Evaluation, and Quality Improvement or Assurance: What’s in a Name? Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP

October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD

Human Subject Protection Judith Birk IRB Health / Behavioral Sciences.

How to Prevent Institutional Shutdowns: Safeguarding Your Human Subjects Research Program A Workshop Sponsored by the Experimental Biology 2005 Societies,

Reality vs Urban Myth: The Truth About Regulations

A. Short term problems / considerations b. Long term mission View of human subjects protection system: SACHRP July 2008 Elizabeth Bankert.

ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.

OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP May 2, 2015.

Secretary’s Advisory Committee on Human Subjects Protections (SACHRP) Summary of Responses on: Advanced Notice of Proposed Rulemaking (ANPRM) on Holding.

Experience and innovation in ethical review. ® An Update and Overview of the US Common Rule Regulations David Borasky, MPH, CIP Copernicus Group IRB CAREB.

Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.

Common Rule and FDA Regulation Comparison David Forster Jeff Cooper Gary Chadwick.

The Secretary’s Advisory Committee on Human Research Protections (SACHRP): Recommendations Regarding the Newborn Screening Reauthorization Act of 2014.

Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators Advanced Notice.

An Update from Public Responsibility in Medicine and Research (PRIM&R) Mariellen Diemand Associate Director for Conferences May 1, 2015.

Status of SACHRP Recommendations July 2003-October 2008 Meeting of the Secretary’s Advisory Committee on Human Research Protections October 27, 2008 Michael.

The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.

Community Based Participatory Research: Considerations for IRBs Puneet Chawla Sahota, Ph.D. Post-doctoral Fellow, National Congress of American Indians.

OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,

OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.

SACHRP PANEL: HOLDING EXTERNAL IRBS ACCOUNTABLE David L. Wynes, Ph.D. Vice President for Research Administration Emory University July 21, 2009.

Updates in Research Protections Karen Allen Director, Research Protections Office of Research November

Research How-To’s in a Community Setting Gregory W. Heath, DHSc, MPH Director of Research.

International Research: Pragmatic and Idealistic Thoughts on Capacity Building and the Protection of Human Subjects Jessica Justman, M.D. Institutional.

Joni Barnard IRB Information Session: EHE Workshop 10/13/2015.

The President’s Cancer Panel 2004/2005 Series Translating Research to Reduce the Burden of Cancer Margaret L. Kripke, Ph.D. January 25, 2005.

Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.

The VA Central irb opportunities and challenges

A well regulated militia being necessary to the security of a free State, the right of the People to keep and bear arms shall.

Risks of Standard of Care (Experimental Aspects of Study) Patrick Herbison Continuing Education for IRB Members.

Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.

Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.

Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.

THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.

Department of Health and Human Services1 Update: October 2006 Public Meeting on Emergency Research Diane Maloney, J.D. Associate Director for Policy FDA.

Christine Yalda, J.D., Ph.D. Chair, Human Research Review Committee Grand Valley State University.

OHRP Update Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research Protections 3 rd Annual Medical Research Summit.

Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.

Updating the Common Rule Governing Human Subjects Research Protections

Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.

What is a Data and Safety Monitoring Plan and how do I get one?

Managing local precedents Three models

Overview - Introduction

Updates to Expedited Review Procedures

Updates to Expedited Review Procedures

Overview - Introduction

Overview - Introduction

Human Research Protection Program (HRPP) Brown Bag Series October 2017

Understanding the Planned Changes to the Federal Policy on Protection of Human Subjects (the Common Rule) Megan Kasimatis Singleton, JD, MBE, CIP Assistant.

Updates to Expedited Review Procedures

Secondary Research with Identifiable Information and Biospecimens

George Alter ICPSR Institute for Social Research

Overview of Changes to Human Subjects Research Regulations

Human Gene Therapy Institutional Review Procedures

Jeremy Sugarman, MD, MPH, MA

Changes to the Common Rule and Single IRB (sIRB)

IRB Harmonization 2016 Review

The Second Annual Medical Research Summit

Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.

Presentation transcript:

OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP April 26, 2014

La connexion historique entre Montréal et Washington

Upcoming Events Internet Research Webinar (May 8 and following) Research Community Fora: Cincinnati, Ohio: May 21 Seattle, Washington: July 31 Philadelphia, Pennsylvania: October 23-24

Secretary’s Advisory Committee on Human Research Protections Internet Research Randomized Cluster Trials Engagement in Research Big Data Research and Protections (TBD) Informed Consent (TBD)

Ongoing Activities Follow-up to the SUPPORT Trial compliance determination and subsequent controversy Follow-up to the Advance Notice of Proposed Rulemaking (ANPRM), “Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators”(July, 2011)

Should the Regulations be Changed? The Common Rule got it wrong, and it’s time to change it. The Common Rule no longer suits the research enterprise well, and so it should be changed.

Changes in Life Expectancy (U.S.A.) 1900: : : : : 78

Changes in Leading Causes/Rates of Death (USA:rank/deaths per 100,000) AllNA/1,548NA/964NA/907NA/860NA/800 Tuberculosis#1/174#7/23 Pneumonia/ Flu #2/161#6/41#5/26#6/31#9/16 Heart Disease #3/145#1/356#1/346#1/285#1/194 Cancer#8/66#2/140#2/169#2/204#2/186 Accidents#4/61#4/49#5/35#5/39 Suicide#8/12#10/12 HIV#9/12 Homicide#10/11 Alzheimer’s#6/27

Changes in Technology

Changes in Research Technology

Changes in the Research/Practice Relationship: Institutions Patient-Centered Outcomes Research Institute (2010) The National Center for Advancing Translational Sciences (2011) The National Institutes of Health (NIH) NIH Collaboratory (2012)

Changes in the Research/Practice Relationship: Research Design Comparative Effectiveness Research Randomized Cluster Trials Pragmatic Clinical Trials Community-Based Participatory Action Research

Changes in Law/Regulation? A Case Example “A well-regulated militia being necessary to the security of a free state, the right of the people to keep and bear arms shall not be infringed.” (1791)

How should the regulations be changed? The regulations could be changed in numerous ways, some for the better, some for the worse.

A Proposal for Change Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators (Advance Notice of Proposed Rulemaking (ANPRM), July, 2011)

ANPRM Proposals Scope of regulatory jurisdiction Single IRB review for domestic multi-site studies Informed Consent improvements Single set of security/confidentiality standards Data Reporting Uniformity of regulatory guidance Biospecimen research Revised tiers of review

Simple vs. Complex

Single IRB review for domestic multi-site studies Simple Informed Consent improvements Simple Single set of security/confidentiality standards Simple Data Reporting Simple Uniformity of regulatory guidance Simple Biospecimen research Complex Revised tiers of review Complex

Review Requirements Under the 1991Common Rule Convened Board No review Expedited

Review Tailored to be Commensurate with Risks Single or Multiple Review? Convened or Expedited Review? Continuing Review or Not? Biospecimen Research? Excused so long as conditions are met? No Review?

Using the Right Bucket

Who will carry the water?